- When Is Risk Highest for Women With Breast Cancer Gene Mutations?
- Higher Pregnancy Weight Tied to Raised Odds for Birth Defects
- Women More Likely to Remember Plus-Size Models
- Less Invasive Procedure May Treat Fibroids Without Harming Fertility
- CDC: Number of U.S. Counties With Zika-Carrying Mosquitoes Up
- Family Hx, Mutation Position Key Variables in BRCA1/2 Cancer Risk
- Weight-Loss Program Aids Black Breast Cancer Survivors
Elizabeth M. Swisher, MD. Dr. Elizabeth M. Swisher comments on the implications of new data from the ARIEL2 trial, an ongoing Phase 2 trial of the novel PARP inhibitor rucaparib in relapsed, high-grade serous or endometrioid ovarian cancer. The new results offer an important insight into the genetic mechanisms behind tumor sensitivity… Dr. Alberto De la Guerra. The Food and Drug Administration has after repeated delays proposed removing metastatic breast cancer as an indication from the Avastin label. The proposal is being contested by Roche/Genentech, the drug’s maker. In this article we review the evidence for and against this decision.
Debbie Miller, RN. Prior to the introduction of the medical community in the natural birth process, any maternal recommendations and guidelines were passed from mother to daughter or through lay midwives, herbal and folk practitioners. Childbirth, though risky, was not considered pathological and the majority did not receive…
The BRCA gene test is used to identify mutations in either one of the two breast cancer susceptibility genes, BRCA1 and BRCA2. Women who have inherited…
Thank you for reading my article. Interesting theory. Lots of research is ongoing to figure out the many ways aspirin does it magic.
Times Online / The Sunday Times voted Doctors Lounge as 3rd best ‘Ask an expert’ website.